revealing a novel mechanism: peripherally administered GLP-1R agonists access the brain via myelinated AVP axons in the ME, bypassing the blood-brain barrier (BBB)
Hence the entire transaction stays digital
"The policy changes around the anti-obesity drug class for the Medicaid program, I think, will be positive policy changes, so that we can focus spending on anti-obesity on those that are likely to see the greatest improvement in health outcomes," said Dominick Pallone, executive director of the Michigan Association of Health Plans
doi: 10.1093/brain/aws009 13
Oral semaglutide and tirzepatide tablets have different stability profiles than injectables
Why some researchers prefer the thigh Thigh injections produce a slightly slower, more gradual absorption curve compared to the abdomen